CN111777629B - Dithiobis-mannobiose-gold nanoprobe, preparation method and application - Google Patents

Dithiobis-mannobiose-gold nanoprobe, preparation method and application Download PDF

Info

Publication number
CN111777629B
CN111777629B CN202010787460.9A CN202010787460A CN111777629B CN 111777629 B CN111777629 B CN 111777629B CN 202010787460 A CN202010787460 A CN 202010787460A CN 111777629 B CN111777629 B CN 111777629B
Authority
CN
China
Prior art keywords
mannobiose
bis
ligand
gold
sulfur
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010787460.9A
Other languages
Chinese (zh)
Other versions
CN111777629A (en
Inventor
刘媛媛
张景意
李壹
张舒萌
徐馨琦
何淑怡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southeast university chengxian college
Original Assignee
Southeast university chengxian college
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southeast university chengxian college filed Critical Southeast university chengxian college
Priority to CN202010787460.9A priority Critical patent/CN111777629B/en
Publication of CN111777629A publication Critical patent/CN111777629A/en
Application granted granted Critical
Publication of CN111777629B publication Critical patent/CN111777629B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/12Gold compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/02Use of particular materials as binders, particle coatings or suspension media therefor
    • C09K11/025Use of particular materials as binders, particle coatings or suspension media therefor non-luminescent particle coatings or suspension media
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18Metal complexes
    • C09K2211/188Metal complexes of other metals not provided for in one of the previous groups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6432Quenching

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)

Abstract

The invention belongs to the field of glycochemistry and biology, and particularly relates to a dithiobis-mannobiose-gold nanoprobe, a preparation method and application thereof in virus receptor DC-SIGN/R recognition. A double-sulfur double-mannose-gold nano probe is characterized in that: modifying the surface of the gold nanoparticles with a dithiobis-mannobiose ligand by a ligand exchange method. According to the invention, based on click chemistry and ligand exchange, a mannobiose ligand is modified on the surface of a gold nanoparticle, a novel dithiobis-mannobiose-gold nanoprobe is constructed, and based on a fluorescence quenching strategy, the sugar binding mechanisms of tetramer lectins DC-SIGN and DC-SIGNR are researched, so that a foundation is laid for establishing a rapid and sensitive method and researching the binding affinity and thermodynamics between protein-sugar multivalent interactions.

Description

Dithiobis-mannobiose-gold nanoprobe, preparation method and application
Technical Field
The invention belongs to the field of glycochemistry and biology, and particularly relates to a dithiobis-mannobiose-gold nanoprobe, a preparation method and application thereof in virus receptor DC-SIGN/R recognition.
Technical Field
C-type lectins are a class containing calcium ions (Ca)2+) The carbohydrate recognition domain-dependent (CRDs) superfamily of proteins, which bind to the surface sugars of various viral glycoproteins, play a key role in many important biological processes, such as innate immunity and serum glycoprotein clearance (Biochemistry,2004,43, 3783-. In 2001, Feinberg topic group (Science,2001,294,2163-2166) reported in Science that two important type II membrane proteins consisting of C-type lectin receptors, DC-SIGN (dendritic Cell surface-specific intercellular adhesion factor-3-binding non-integrin factor) and DC-SIGNR (endothelial Cell receptor closely related to DC-SIGN), were bound to oligosaccharide in the CRD crystal structure (Cell,2000,100,587)-597). The two have high affinity to sugar-containing molecules, especially mannose, such as mannose existing on the surface of HIV and Ebola virus glycoprotein, and viral infection can be promoted by combining hydroxyl on a mannose pyran ring with CRD of protein.
DC-SIGN and DC-SIGNR are closely related to the occurrence of body infectious diseases as important recognition receptors of pathogenic microorganisms such as viruses and bacteria. Despite the extensive research performed by scientists over the past 20 years, the detailed protein structure remains unknown except for structural models based on solution X-ray scattering data (without X-ray crystallography validation).
The gold nanoparticles not only have size-dependent and adjustable fluorescence spectrum, high quantum efficiency and large Stokes shift, but also have the advantages of small particle size, no toxicity, good biocompatibility and the like which are not possessed by fluorescent dyes, quantum dots and the like, so that the gold nanoparticles become an ideal fluorescent probe.
The invention aims to prepare a dithiobis-mannobiose-gold nanoprobe, discusses the interaction with tetramer agglutinin DC-SIGN and DC-SIGNR, and lays a foundation for developing specific multivalent inhibition blocking DC-SIGN/R mediated virus infection.
Disclosure of Invention
The invention aims to provide a dithiobis-mannobiose-gold nanoprobe, a preparation method and application thereof in virus receptor DC-SIGN/R recognition.
A double-sulfur double-mannose-gold nano probe is characterized in that: modifying the surface of the gold nanoparticles with a dithiobis-mannobiose ligand by adopting a ligand exchange method, wherein the structure is shown as a formula I:
Figure BDA0002622521690000021
x is 1 to 1500.
The object of the invention can be achieved by the following measures:
the bis-mannose bis-gold nanoprobe (i.e., the substance of formula I) was prepared as follows: dissolving 1 mol of gold nanoparticles, 1-2000 mol of bis-sulfur bis-mannobiose ligand II and 1-2500 mol of tris (2-carboxyethyl) phosphine (TCEP) in ultrapure water, stirring at room temperature in a dark place for 12-24 h, concentrating, washing with water, and preparing a bis-sulfur bis-mannobiose-gold nanoprobe I, wherein the process comprises the following steps:
Figure BDA0002622521690000022
the disulfide bis-mannobiose ligand shown in the general formula II is prepared from mannobiose ligand III, disulfide ligand IV, tert-butyl trichloroacetimidate (TBTA), copper sulfate pentahydrate and sodium ascorbate through click chemistry. Wherein the molar ratio of the disulfide ligand IV to the mannobiose ligand III to the tert-butyl trichloroacetimidate (TBTA) to the copper sulfate pentahydrate to the sodium ascorbate is 1: 2-3: 0.1-0.3: 0.05-0.2: 0.1-1, and stirring the mixture at room temperature in a dark place by using a solvent methanol or ethanol, wherein the product is separated and purified by column chromatography. The specific reaction formula is as follows:
Figure BDA0002622521690000031
according to the synthesis references of mannobiose ligands shown in the general formula III J.Am.chem.Soc.2017,139,11833-11844, mannose and peracetyl mannose are used as raw materials and react with acetic anhydride, phosphorus tribromide, hydrazine acetate, trichloroacetonitrile and DBU respectively to prepare III-4 and III-5. Then reacting with boron trifluoride ethyl ether solution at low temperature to prepare III-3. Reference is made to the synthesis of III-5 for preparation of III-2. III-2 is sequentially reacted with H (OCH)2CH2)3Cl and NaN3And reacting to prepare III-1. Finally, III-1 is hydrolyzed under alkaline condition to prepare the mannobiose III, and the specific reaction formula is as follows:
Figure BDA0002622521690000032
the disulfide ligand IV is prepared by taking aspartic acid as a raw material, sequentially reacting with di-tert-butyl dicarbonate and alkynylamine IV-1 to prepare Boc-protected alkynylamine IV-3, then deprotecting, and condensing with lipoic acid through DCC, and the specific reaction formula is as follows:
Figure BDA0002622521690000041
the application of the bis-sulfur bis-mannobiose-gold nanoprobe in preparing a virus receptor DC-SIGN/R detection reagent.
Advantageous effects
According to the invention, based on click chemistry and ligand exchange, a mannobiose ligand is modified on the surface of a gold nanoparticle, a novel dithiobis-mannobiose-gold nanoprobe is constructed, and based on a fluorescence quenching strategy, the sugar binding mechanisms of tetramer lectins DC-SIGN and DC-SIGNR are researched, so that a foundation is laid for establishing a rapid and sensitive method and researching the binding affinity and thermodynamics between protein-sugar multivalent interactions.
Drawings
FIG. 1 shows a high resolution mass spectrum of a bis-sulfur bis-mannobiose ligand II (n-2).
FIG. 2 shows the UV-VIS absorption spectrum of the bis-mannose-gold nanoprobe I.
FIG. 3 is a dynamic light scattering characterization of the bis-mannose-gold nanoprobe I.
FIG. 4 is a graph showing the binding of the bis-mannose-gold nanoprobe I to DC-SIGN.
FIG. 5 is a graph showing the binding of the bis-mannobiose gold nanoprobe I to DC-SIGNR.
Detailed Description
The following specific examples are provided to further illustrate the invention.
The starting gold nanoparticles (5 nm in diameter, dispersed in PBS solution) were purchased from Sigma-Aldrich.
Synthetic examples
Example 1
Synthesis of Compound III-4
Figure BDA0002622521690000051
Dissolving mannose in acetic anhydride, adding a few drops of perchloric acid, stirring at room temperature for 1 hour, cooling to 10 ℃, dropwise adding phosphorus tribromide, and controlling the temperature to be 20-25 ℃. After the completion of the dropping, the mixture was stirred at room temperature for 1.5 hours. Cooling to 5 deg.C, adding sodium acetate solution, controlling temperature at 20-25 deg.C, and stirring for 20 min. Chloroform extraction, saturated sodium bicarbonate solution and water washing, drying with anhydrous sodium sulfate, filtration and concentration. Recrystallization from cold ether afforded compound III-4 as a white solid at m.p.132-133 ℃. High resolution mass spectrometry data: [ M + NH ]4]+366.1395 (theoretical), 366.1400 (measured).
Example 2
Synthesis of Compound III-5
Figure BDA0002622521690000052
Under the protection of nitrogen, dissolving the total acetyl alpha-D-mannose in DMF, heating to 50 ℃, adding hydrazine acetate, stirring for 20 minutes, cooling, adding ethyl acetate, washing with saturated saline solution, drying with anhydrous sodium sulfate, filtering and concentrating. Dichloromethane was added, cooled to-10 ℃, trichloroacetonitrile and Diazabicyclo (DBU) were added dropwise, and the mixture was allowed to warm to room temperature and stirred for 2 hours. Concentrating, separating by column chromatography to obtain compound III-5 as colorless liquid. High resolution mass spectrometry data: [2M + Na ]]+1005.0198 (theoretical), 1005.0175 (measured).
Example 3
Synthesis of Compound III-3
Figure BDA0002622521690000053
The compounds III-4 and III-5 were co-distilled with toluene, followed by addition of anhydrous dichloromethane and 4A type molecular sieve, and stirring at room temperature for 2 hours. Cooling to-50 deg.C, adding boron trifluoride ether solution, slowly heating to room temperature, and reacting for 18 hr. Adding sodium bicarbonate, filtering, concentrating, separating by column chromatography, and making into desired dosage formCompound III-3, white solid, m.p.70-71 ℃. High resolution mass spectrometry data: [ M + Na ]]+701.1900 (theoretical), 701.1904 (measured).
Example 4
Synthesis of Compound III-2
Figure BDA0002622521690000061
Dissolving compound III-3 in DMF, heating to 50 deg.C, adding hydrazine acetate, stirring for 20 min, cooling, adding ethyl acetate, washing with saturated saline solution, drying with anhydrous sodium sulfate, filtering, and concentrating. Adding dichloromethane, cooling to-10 ℃, dropwise adding trichloroacetonitrile and DBU, slowly raising the temperature to room temperature after dropwise adding, and stirring for 2 hours. Concentrating, separating by column chromatography to obtain compound III-2, yellow liquid. High resolution mass spectrometry data: [ M + Na ]]+802.0906 (theoretical), 802.0906 (measured).
Example 5
Synthesis of Compound III-1
Figure BDA0002622521690000062
The compound III-2 and toluene are steamed together, and then anhydrous dichloromethane is added,
Figure BDA0002622521690000063
Stirring the molecular sieve and 2-chloroethoxy-2-ethoxy diethanol at room temperature for 1.5 hours, cooling to-50 ℃, adding boron trifluoride diethyl etherate, and heating to 2 ℃ within 2 hours. Washed with saturated sodium bicarbonate solution and brine, dried over anhydrous sodium sulfate, filtered, and concentrated. Adding anhydrous DMF and NaN3And TBAI, stirred at 87 ℃ for 17 hours. Concentrating, separating by column chromatography to obtain compound III-1 as colorless liquid. High resolution mass spectrometry data: [ M + Na ]]+816.2586 (theoretical), 816.2589 (measured).
Example 6
Synthesis of mannobiose ligand III
Figure BDA0002622521690000071
Hydrolyzing the compound III-1 under alkaline condition to prepare the mannobiose ligand III as colorless liquid. Nuclear magnetic data (1H NMR,400MHz, internal standard TMS, solvent CDCl3) The following were used: delta ppm 5.03(d,1H, J)1a,2a1.7Hz,H-1a),4.94(d,1H,J1b,2b 1.7Hz,H-1b),3.98(dd,1H,J2b,3b 3.4Hz,J1b,2b 1.7Hz,H-2b),3.90(dd,1H,J2a,3a3.4Hz,J1a,2a 1.7Hz,H-2a),3.82-3.76(m,5H,H-3a,H-3b,H-6,H-6’,CH2O),3.70-3.53(m,15H,C-4a,C-4b,C-5a,C-5b,C-6,C-6,CH2O),3.42(t,2H,J 4.87Hz,CH2-N); high resolution mass spectrometry data: [ M + Na ]]+522.2352 (theoretical), 522.1905 (measured).
Example 7
Synthesis of alkynylamine IV-1(n ═ 2)
Figure BDA0002622521690000072
Mixing diglycolamine 10mL, tetrahydrofuran 100mL and H2O100mL, 24.0g of di-tert-butyl dicarbonate and 31.8g of sodium carbonate were added thereto, and after stirring at room temperature for 24 hours, the pH was adjusted to about 5 with 2mol/L hydrochloric acid, followed by extraction with ethyl acetate, drying over anhydrous sodium sulfate, filtration, rotary evaporation, and dissolution in 30mL of tetrahydrofuran. And (3) adding 3.93g NaH into the mixed solution in an ice bath, stirring the mixed solution for 10 minutes, adding 4.48mL of bromopropyne, stirring the mixed solution for 4 hours at room temperature, adjusting the pH to be about 6 to 7 by using 2M hydrochloric acid, extracting an aqueous layer by using ethyl acetate, drying the aqueous layer by using anhydrous sodium sulfate, performing rotary evaporation, and performing column chromatography separation to prepare the alkynylamine IV-1 as a light yellow liquid. Mass spectrometry data: [ M + H ]]+144.10 (theoretical), 144.12 (measured).
Example 8
Synthesis of Boc protected aspartic acid IV-2
Figure BDA0002622521690000081
2g of aspartic acid, 10mL of dioxane and 30mLH2And mixing, adding 30mL of sodium hydroxide (1M) while stirring until the solution is clear, cooling in an ice bath, dropwise adding 10mL of dioxane solution of di-tert-butyl dicarbonate (3.6g), and stirring at room temperature overnight after dropwise adding. Rotary evaporation, addition of 20mL ethyl acetate, acidification with HCl (3M) to pH 2, drying over anhydrous sodium sulfate, filtration, rotary evaporation, column chromatography separation to afford Boc protected aspartic acid IV-2. Mass spectrometry data: [ M + H ]]+234.10 (theoretical), 234.11 (measured).
Example 9
Synthesis of Boc-protected alkynylamide IV-3(n ═ 2)
Figure BDA0002622521690000082
4.16g of compound IV-2, 11.03g of DCC and 30mL of dichloromethane are mixed, stirred and reacted for 1 hour at 0 ℃, 5.11g of alkynylamine IV-1 and a catalytic amount of DMAP are added, the temperature is slowly raised to room temperature, the mixture is stirred overnight, filtered, rotary-evaporated and separated by column chromatography, and Boc protected alkynylamide IV-3 is prepared as a yellow viscous liquid. Mass spectrometry data: [ M + H ]]+484.27 (theoretical), 484.26 (measured).
Example 10
Synthesis of alkynylamide IV-4(n ═ 2)
Figure BDA0002622521690000083
To a solution of compound IV-3(0.5g) in dichloromethane (10mL) at 0 ℃ was added 0.5mL of trifluoroacetic acid, stirred at 0 ℃ for 2.5 hours, rotary evaporated, and dissolved in 10mL of methanol. Cooling to 5 ℃, adding 0.03g of potassium carbonate, stirring for 30 minutes, extracting with ethyl acetate, drying with anhydrous sodium sulfate, performing rotary evaporation, and performing column chromatography separation to prepare the alkynylamide IV-4 as a light yellow viscous liquid. Mass spectrometry data: [ M + H ]]+384.21 (theoretical), 384.24 (measured).
Example 11
Synthesis of Dithiobis-mannobiose ligand II (n ═ 2)
Figure BDA0002622521690000091
Mixing disulfide ligand IV (0.38g, 1mmol) and mannobiose ligand III (1.0g, 2mmol) in methanol, adding TBTA (0.042g, 0.19mmol) and CuSO4·5H2O (0.028g, 0.11mmol) and sodium ascorbate (0.08g, 0.41mmol) are stirred at room temperature in the dark, and subjected to rotary evaporation and column chromatography separation to prepare the dithiobis-mannobiose ligand II. The results of high resolution mass spectrometry (FIG. 1) show: [ M + Na + K ]]2+815.7968 (theoretical), 815.8078 (measured).
Example 12
Synthesis of bis-mannobiose gold nanoprobe I (n ═ 2)
Figure BDA0002622521690000092
2mL of gold nanoparticles (91mM) in PBS was concentrated to 200. mu.L, and bis-sulfur-bis-mannobiose ligand II (0.3g, 0.36mol) and TCEP (0.124g, 0.432mol) were added thereto, followed by stirring overnight at room temperature in the dark. Concentrating, washing with water, preparing dithiobis-mannobiose-gold nanoprobe I, and characterizing by ultraviolet visible absorption spectrum (figure 2) and dynamic light scattering (figure 3), wherein lambda ismaxAt 530nm, the average particle size was 14.62 nm.
Example 13
Fluorescence quenching experiment
According to the experimental scheme shown in Table 1, the fluorescence spectrum of the bis-mannose-gold nanoprobe I + DC-SIGN/R and the fluorescence spectrum of the DC-SIGN/R (the excitation wavelength is 597nm) at different concentrations are respectively measured, and the fluorescence quenching efficiency QE% is calculated according to the formula (X-Y)/X (X, Y is the spectral peak area of the DC-SIGN/R, the sugar nanoprobe + DC-SIGN/R respectively). Using a Hill equation to fit and Origin software to draw a binding curve to obtain the binding affinity Kd. The results show that: the bonding force of the bis-mannose-gold nanoprobe I and the DC-SIGN is strong, the fluorescent quenching phenomenon is obvious after the two are mixed, and Kd5.74 (fig. 4); and binding to DC-SIGNRSlightly weak force, Kd55.30 (fig. 5). The buffer solutions used in the experiments were: NaCl (100mM), HEPES (20mM), CaCl2(10mM), containing 1mg/mL BSA solution.
TABLE 1 fluorescence quenching Experimental protocol
Figure BDA0002622521690000101

Claims (4)

1. A double-sulfur double-mannose-gold nano probe is characterized in that: modifying the surface of the gold nanoparticles with a dithiobis-mannobiose ligand by adopting a ligand exchange method, wherein the structure is shown as a formula I:
Figure FDA0003473128160000011
x is 1 to 1500, and n is 1 to 10.
2. The method for preparing the dithiobis-mannobiose-gold nanoprobe of claim 1, which is characterized by comprising the following steps:
dissolving 1 mole of gold nanoparticles, 1-2000 moles of bis-sulfur bis-mannobiose ligand II and 1-2500 moles of tris (2-carboxyethyl) phosphine in ultrapure water, stirring at room temperature in a dark place for 12-24 hours, concentrating, washing with water, and preparing a bis-sulfur bis-mannobiose-gold nanoprobe I, wherein the reaction formula is as follows:
Figure FDA0003473128160000012
wherein n is 1-10.
3. The method for preparing the bis-sulfur bis-mannobiose-gold nanoprobe according to claim 2, wherein the bis-sulfur bis-mannobiose ligand II is prepared by click chemistry from a mannobiose ligand III, a bis-sulfur ligand IV, tert-butyl trichloroacetimidate, copper sulfate pentahydrate and sodium ascorbate, and has the reaction formula:
Figure FDA0003473128160000013
wherein: n is 1-10;
the molar ratio of the disulfide ligand IV to the mannobiose ligand III to the tert-butyl trichloroacetimidate to the copper sulfate pentahydrate to the sodium ascorbate is 1: 2-3: 0.1-0.3: 0.05-0.2: 0.1-1, using methanol or ethanol as a solvent, stirring at room temperature in a dark place, and separating and purifying a product by column chromatography.
4. The use of the bis-sulfur bis-mannobiose-gold nanoprobe of claim 1 in the preparation of a virus receptor DC-SIGN/R detection reagent.
CN202010787460.9A 2020-08-07 2020-08-07 Dithiobis-mannobiose-gold nanoprobe, preparation method and application Active CN111777629B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010787460.9A CN111777629B (en) 2020-08-07 2020-08-07 Dithiobis-mannobiose-gold nanoprobe, preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010787460.9A CN111777629B (en) 2020-08-07 2020-08-07 Dithiobis-mannobiose-gold nanoprobe, preparation method and application

Publications (2)

Publication Number Publication Date
CN111777629A CN111777629A (en) 2020-10-16
CN111777629B true CN111777629B (en) 2022-03-29

Family

ID=72766028

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010787460.9A Active CN111777629B (en) 2020-08-07 2020-08-07 Dithiobis-mannobiose-gold nanoprobe, preparation method and application

Country Status (1)

Country Link
CN (1) CN111777629B (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Probing Multivalent Lectin-Carbohydrate Binding via Multifunctional Glycan-Gold Nanoparticles: Implications for Blocking Virus Infection;Darshita Budhadev等;《ChemRxiv》;20200629;全文 *

Also Published As

Publication number Publication date
CN111777629A (en) 2020-10-16

Similar Documents

Publication Publication Date Title
CN113461609B (en) Sulfatase-responsive AIE nano probe and preparation method and application thereof
CN112010817A (en) Method for preparing tetrazine compound and application thereof
CN111777629B (en) Dithiobis-mannobiose-gold nanoprobe, preparation method and application
CN106083993B (en) Parents' polypeptide amine dendrimer and preparation method thereof
US20080194801A1 (en) Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
CN110437283B (en) Potassium ion fluorescent probe and preparation method and application thereof
CN105158467A (en) Biological probe used for detecting tumour marker galectin-1 and preparation method thereof
CN115073435B (en) Near infrared fluorescent probe for detecting hydrogen sulfide and preparation method thereof
CN107917903A (en) Application of the glycosyl low-dimensional materials in influenza A virus fluoroscopic examination
CN101531683B (en) Bipyridine ruthenium/osmium ECL marker with phenothiazine power supplying groups in molecules
WO2010027108A1 (en) Fluorescent sugar derivative compound and sensor using same
CN114437053A (en) Nano probe and application thereof in detecting superoxide anion in Golgi apparatus
JP3746181B2 (en) Phenyldiazirine compounds and photoaffinity labeling reagents
CN109929003B (en) Tetraphenylethylene compound containing sialic acid glycosyl unit, preparation method and application
CN116574081B (en) Chlorogenic acid-Huang Qinsu conjugate and preparation method and application thereof
KR100670948B1 (en) A bundle of carbohydrates covalently bonded to single molecule of cucurbituril derivative
KR101322615B1 (en) Thiol-targeting chemodosimetric fluorescent probe, method for preparing the same, and method for bioimaging of thiol using the same
CN113527364B (en) Mn (II) complex multi-photon absorption material and preparation method and application thereof
CN110563795A (en) Preparation method and application of diosgenin derivative containing 1,3,4 oxadiazole or 1,3,4 thiadiazole fragment
CN114853743B (en) Cytosine-based cyanine probe and preparation method and application thereof
CN114736150B (en) off-DNA and on-DNA synthesis method of arylselenoindole compound
WO2003016423A1 (en) Hydrogelation agents
Leikauf et al. A new colorimetric protecting group allowing deprotection under neutral conditions
CN1803822A (en) Method for preparing adenosine
CN108148152B (en) Zanamivir polymaleic anhydride conjugate and synthesis method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant